Concepts (306)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Body Composition | 60 | 2025 | 265 | 10.280 |
Why?
|
| Milk, Human | 25 | 2024 | 86 | 6.940 |
Why?
|
| Breast Feeding | 26 | 2024 | 94 | 4.330 |
Why?
|
| Child Development | 14 | 2024 | 78 | 3.750 |
Why?
|
| Plethysmography | 20 | 2020 | 27 | 3.720 |
Why?
|
| Adipose Tissue | 21 | 2025 | 183 | 2.520 |
Why?
|
| Weight Gain | 11 | 2021 | 75 | 2.470 |
Why?
|
| Obesity | 23 | 2022 | 669 | 2.240 |
Why?
|
| Infant | 33 | 2024 | 1004 | 2.040 |
Why?
|
| Adiposity | 14 | 2024 | 94 | 1.970 |
Why?
|
| Body Mass Index | 29 | 2022 | 399 | 1.940 |
Why?
|
| Body Weight | 22 | 2019 | 250 | 1.880 |
Why?
|
| Absorptiometry, Photon | 21 | 2020 | 100 | 1.810 |
Why?
|
| Infant Nutritional Physiological Phenomena | 6 | 2021 | 36 | 1.740 |
Why?
|
| Fructose | 5 | 2022 | 22 | 1.740 |
Why?
|
| Female | 83 | 2024 | 15153 | 1.590 |
Why?
|
| Anthropometry | 11 | 2020 | 93 | 1.390 |
Why?
|
| Infant, Newborn | 23 | 2024 | 885 | 1.330 |
Why?
|
| Humans | 103 | 2025 | 28094 | 1.300 |
Why?
|
| Leptin | 7 | 2022 | 67 | 1.280 |
Why?
|
| MicroRNAs | 3 | 2022 | 301 | 1.250 |
Why?
|
| Body Water | 12 | 2016 | 19 | 1.240 |
Why?
|
| Oligosaccharides | 3 | 2023 | 33 | 1.220 |
Why?
|
| Insulin | 7 | 2021 | 315 | 1.140 |
Why?
|
| Male | 63 | 2024 | 13489 | 1.120 |
Why?
|
| Reproducibility of Results | 24 | 2024 | 769 | 1.080 |
Why?
|
| Electric Impedance | 9 | 2020 | 30 | 1.040 |
Why?
|
| Pregnancy | 20 | 2024 | 1191 | 1.030 |
Why?
|
| Diabetes, Gestational | 6 | 2024 | 68 | 1.000 |
Why?
|
| Glucose | 5 | 2021 | 204 | 1.000 |
Why?
|
| Interleukin-6 | 4 | 2021 | 193 | 0.980 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 111 | 0.950 |
Why?
|
| Metabolome | 3 | 2024 | 68 | 0.870 |
Why?
|
| Pediatric Obesity | 4 | 2021 | 71 | 0.870 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 247 | 0.820 |
Why?
|
| Adult | 39 | 2024 | 7739 | 0.800 |
Why?
|
| Exosomes | 2 | 2022 | 96 | 0.800 |
Why?
|
| Adipokines | 3 | 2022 | 9 | 0.760 |
Why?
|
| Carbonated Beverages | 2 | 2018 | 3 | 0.740 |
Why?
|
| Hormones | 2 | 2022 | 43 | 0.720 |
Why?
|
| Lactation | 7 | 2024 | 61 | 0.690 |
Why?
|
| Birth Weight | 5 | 2019 | 63 | 0.680 |
Why?
|
| Body Fluid Compartments | 3 | 2019 | 4 | 0.670 |
Why?
|
| Air | 4 | 2012 | 23 | 0.660 |
Why?
|
| Overweight | 6 | 2017 | 113 | 0.660 |
Why?
|
| Thiazines | 1 | 2018 | 1 | 0.590 |
Why?
|
| Non-Nutritive Sweeteners | 1 | 2018 | 1 | 0.590 |
Why?
|
| Energy Metabolism | 7 | 2015 | 200 | 0.580 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 5 | 2019 | 64 | 0.580 |
Why?
|
| Sucrose | 1 | 2018 | 27 | 0.580 |
Why?
|
| Students | 4 | 2007 | 196 | 0.580 |
Why?
|
| Prospective Studies | 14 | 2024 | 1248 | 0.580 |
Why?
|
| Women's Health | 2 | 2007 | 60 | 0.550 |
Why?
|
| Growth | 2 | 2015 | 24 | 0.530 |
Why?
|
| Mothers | 5 | 2023 | 122 | 0.520 |
Why?
|
| Walking | 2 | 2008 | 135 | 0.510 |
Why?
|
| Athletes | 7 | 2016 | 70 | 0.480 |
Why?
|
| Body Height | 7 | 2018 | 57 | 0.470 |
Why?
|
| Adolescent | 18 | 2016 | 3121 | 0.460 |
Why?
|
| Child | 17 | 2022 | 2242 | 0.450 |
Why?
|
| Diet | 4 | 2019 | 232 | 0.450 |
Why?
|
| Models, Biological | 8 | 2025 | 466 | 0.430 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2015 | 123 | 0.430 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2024 | 123 | 0.400 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 819 | 0.390 |
Why?
|
| Martial Arts | 4 | 2012 | 6 | 0.380 |
Why?
|
| Cohort Studies | 8 | 2024 | 887 | 0.380 |
Why?
|
| Cross-Sectional Studies | 11 | 2018 | 961 | 0.380 |
Why?
|
| Aging | 6 | 2015 | 968 | 0.370 |
Why?
|
| Oklahoma | 7 | 2018 | 1007 | 0.350 |
Why?
|
| Exercise | 6 | 2015 | 479 | 0.340 |
Why?
|
| Monitoring, Physiologic | 2 | 2007 | 57 | 0.340 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 366 | 0.340 |
Why?
|
| Young Adult | 17 | 2020 | 2732 | 0.340 |
Why?
|
| Reference Values | 6 | 2019 | 199 | 0.330 |
Why?
|
| Dielectric Spectroscopy | 4 | 2012 | 6 | 0.330 |
Why?
|
| Lung Volume Measurements | 2 | 2006 | 4 | 0.320 |
Why?
|
| Gestational Age | 2 | 2019 | 146 | 0.300 |
Why?
|
| Longitudinal Studies | 7 | 2019 | 414 | 0.300 |
Why?
|
| Thorax | 2 | 2007 | 29 | 0.300 |
Why?
|
| Infant Formula | 2 | 2020 | 18 | 0.300 |
Why?
|
| Sex Characteristics | 4 | 2021 | 172 | 0.290 |
Why?
|
| Physical Exertion | 2 | 2008 | 104 | 0.290 |
Why?
|
| Basal Metabolism | 2 | 2006 | 10 | 0.280 |
Why?
|
| Seasons | 1 | 2007 | 89 | 0.280 |
Why?
|
| Adiponectin | 2 | 2019 | 29 | 0.280 |
Why?
|
| Holidays | 1 | 2006 | 4 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 331 | 0.260 |
Why?
|
| Research Design | 2 | 2024 | 184 | 0.260 |
Why?
|
| Plethysmography, Whole Body | 2 | 2011 | 2 | 0.260 |
Why?
|
| United States | 7 | 2022 | 2146 | 0.260 |
Why?
|
| Linear Models | 5 | 2015 | 202 | 0.250 |
Why?
|
| Lipids | 2 | 2022 | 208 | 0.250 |
Why?
|
| Age Factors | 5 | 2015 | 734 | 0.250 |
Why?
|
| Immersion | 1 | 2005 | 4 | 0.250 |
Why?
|
| Universities | 1 | 2006 | 120 | 0.250 |
Why?
|
| Terminology as Topic | 1 | 2025 | 56 | 0.240 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 297 | 0.230 |
Why?
|
| Kynurenine | 1 | 2024 | 21 | 0.230 |
Why?
|
| Cytomegalovirus | 1 | 2024 | 22 | 0.230 |
Why?
|
| Postpartum Period | 3 | 2019 | 72 | 0.230 |
Why?
|
| Cytomegalovirus Infections | 1 | 2024 | 36 | 0.220 |
Why?
|
| Sensitivity and Specificity | 5 | 2016 | 521 | 0.220 |
Why?
|
| Body Fat Distribution | 4 | 2013 | 15 | 0.210 |
Why?
|
| Sports | 2 | 2016 | 23 | 0.210 |
Why?
|
| Oxygen Consumption | 6 | 2013 | 181 | 0.210 |
Why?
|
| Models, Theoretical | 2 | 2013 | 134 | 0.200 |
Why?
|
| Bone Density | 4 | 2022 | 100 | 0.190 |
Why?
|
| Motor Activity | 3 | 2013 | 148 | 0.190 |
Why?
|
| Biomedical Research | 2 | 2013 | 97 | 0.190 |
Why?
|
| Risk Factors | 3 | 2019 | 2081 | 0.190 |
Why?
|
| Sugars | 1 | 2021 | 4 | 0.190 |
Why?
|
| Betaine | 1 | 2021 | 4 | 0.180 |
Why?
|
| Middle Aged | 11 | 2019 | 7137 | 0.180 |
Why?
|
| Research | 3 | 2024 | 92 | 0.180 |
Why?
|
| Oleic Acids | 1 | 2021 | 3 | 0.180 |
Why?
|
| Adipose Tissue, Brown | 1 | 2021 | 14 | 0.180 |
Why?
|
| Fruit and Vegetable Juices | 1 | 2020 | 5 | 0.180 |
Why?
|
| Child, Preschool | 5 | 2020 | 1146 | 0.180 |
Why?
|
| Weight Loss | 2 | 2015 | 81 | 0.180 |
Why?
|
| Infant Health | 1 | 2020 | 2 | 0.170 |
Why?
|
| Body Weights and Measures | 1 | 2020 | 18 | 0.170 |
Why?
|
| Water | 2 | 2015 | 135 | 0.170 |
Why?
|
| Clothing | 1 | 2000 | 4 | 0.170 |
Why?
|
| Muscle, Skeletal | 2 | 2011 | 634 | 0.160 |
Why?
|
| Area Under Curve | 2 | 2018 | 95 | 0.160 |
Why?
|
| Cytokines | 1 | 2022 | 447 | 0.160 |
Why?
|
| Indicator Dilution Techniques | 3 | 2016 | 7 | 0.160 |
Why?
|
| High Fructose Corn Syrup | 1 | 2018 | 1 | 0.150 |
Why?
|
| Isotopes | 2 | 2012 | 10 | 0.150 |
Why?
|
| Infant, Premature | 1 | 2019 | 141 | 0.140 |
Why?
|
| Random Allocation | 2 | 2015 | 151 | 0.140 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 1013 | 0.140 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 92 | 0.140 |
Why?
|
| Cognition | 1 | 2020 | 324 | 0.140 |
Why?
|
| Radioisotope Dilution Technique | 2 | 2009 | 14 | 0.130 |
Why?
|
| Muscle Contraction | 1 | 1997 | 170 | 0.120 |
Why?
|
| Whey Proteins | 1 | 2015 | 13 | 0.120 |
Why?
|
| Pregnancy in Diabetics | 1 | 2015 | 21 | 0.120 |
Why?
|
| Nursing Homes | 2 | 1994 | 48 | 0.120 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2015 | 36 | 0.120 |
Why?
|
| Pericardium | 1 | 2015 | 47 | 0.120 |
Why?
|
| Child of Impaired Parents | 1 | 2015 | 6 | 0.120 |
Why?
|
| Models, Statistical | 2 | 2013 | 128 | 0.120 |
Why?
|
| Echocardiography | 1 | 2015 | 108 | 0.120 |
Why?
|
| Risk | 1 | 2015 | 137 | 0.120 |
Why?
|
| Predictive Value of Tests | 4 | 2013 | 474 | 0.120 |
Why?
|
| Human Development | 1 | 2015 | 4 | 0.120 |
Why?
|
| Choice Behavior | 1 | 2015 | 28 | 0.120 |
Why?
|
| Postprandial Period | 2 | 2019 | 44 | 0.110 |
Why?
|
| Blood Glucose | 2 | 2019 | 309 | 0.110 |
Why?
|
| Basal Ganglia Diseases | 1 | 1994 | 3 | 0.110 |
Why?
|
| Rest | 1 | 2015 | 94 | 0.110 |
Why?
|
| Antipsychotic Agents | 1 | 1994 | 24 | 0.110 |
Why?
|
| Regression Analysis | 3 | 2005 | 210 | 0.110 |
Why?
|
| Skinfold Thickness | 2 | 2013 | 19 | 0.110 |
Why?
|
| Heart Rate | 2 | 2013 | 379 | 0.110 |
Why?
|
| Accelerometry | 1 | 2013 | 12 | 0.110 |
Why?
|
| Surveys and Questionnaires | 2 | 2007 | 971 | 0.110 |
Why?
|
| Indians, North American | 2 | 2015 | 520 | 0.110 |
Why?
|
| Blood Pressure | 2 | 2011 | 354 | 0.110 |
Why?
|
| Torso | 1 | 2013 | 5 | 0.100 |
Why?
|
| Aged | 7 | 2007 | 5400 | 0.100 |
Why?
|
| Muscle Strength | 2 | 2011 | 230 | 0.100 |
Why?
|
| Drug Utilization | 1 | 1992 | 28 | 0.100 |
Why?
|
| Deuterium | 4 | 2016 | 50 | 0.100 |
Why?
|
| Psychotropic Drugs | 1 | 1992 | 8 | 0.100 |
Why?
|
| Bloodletting | 1 | 1992 | 2 | 0.100 |
Why?
|
| Pulse | 1 | 1992 | 4 | 0.100 |
Why?
|
| Posture | 1 | 1992 | 39 | 0.100 |
Why?
|
| African Americans | 3 | 2006 | 352 | 0.100 |
Why?
|
| Bias | 1 | 2012 | 42 | 0.090 |
Why?
|
| Sex Factors | 2 | 2013 | 466 | 0.090 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 110 | 0.090 |
Why?
|
| Forearm | 1 | 2011 | 39 | 0.090 |
Why?
|
| Portugal | 2 | 2012 | 3 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 391 | 0.090 |
Why?
|
| Radial Artery | 1 | 2011 | 21 | 0.090 |
Why?
|
| Apolipoprotein C-III | 1 | 2010 | 12 | 0.090 |
Why?
|
| Software | 1 | 2012 | 125 | 0.090 |
Why?
|
| Algorithms | 2 | 2006 | 430 | 0.090 |
Why?
|
| Glucose Tolerance Test | 2 | 2022 | 60 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2012 | 433 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2015 | 668 | 0.080 |
Why?
|
| Term Birth | 1 | 2009 | 10 | 0.080 |
Why?
|
| Bromides | 3 | 2016 | 5 | 0.080 |
Why?
|
| Pulmonary Gas Exchange | 2 | 2007 | 8 | 0.080 |
Why?
|
| Fetal Blood | 2 | 2022 | 39 | 0.080 |
Why?
|
| Functional Residual Capacity | 2 | 2006 | 2 | 0.080 |
Why?
|
| Hyperlipidemias | 1 | 2008 | 37 | 0.070 |
Why?
|
| Triglycerides | 1 | 2008 | 121 | 0.070 |
Why?
|
| Mass Media | 1 | 2008 | 8 | 0.070 |
Why?
|
| Lipoproteins | 1 | 2008 | 99 | 0.070 |
Why?
|
| Midwestern United States | 1 | 2007 | 38 | 0.070 |
Why?
|
| Thinness | 2 | 2007 | 18 | 0.070 |
Why?
|
| Massachusetts | 2 | 2021 | 16 | 0.070 |
Why?
|
| Gases | 1 | 2007 | 23 | 0.070 |
Why?
|
| Calorimetry, Indirect | 1 | 2006 | 14 | 0.070 |
Why?
|
| Physical Education and Training | 1 | 2007 | 48 | 0.070 |
Why?
|
| Health Status | 1 | 2007 | 148 | 0.070 |
Why?
|
| Waist-Hip Ratio | 1 | 2006 | 9 | 0.070 |
Why?
|
| Alabama | 1 | 2006 | 4 | 0.070 |
Why?
|
| Body Surface Area | 1 | 2006 | 7 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2007 | 106 | 0.060 |
Why?
|
| Health Promotion | 1 | 2008 | 176 | 0.060 |
Why?
|
| Italy | 2 | 2019 | 13 | 0.060 |
Why?
|
| Hydrostatic Pressure | 1 | 2005 | 3 | 0.060 |
Why?
|
| Tidal Volume | 1 | 2004 | 6 | 0.060 |
Why?
|
| Writing | 1 | 2024 | 14 | 0.060 |
Why?
|
| Science | 1 | 2024 | 18 | 0.060 |
Why?
|
| Research Report | 1 | 2024 | 23 | 0.060 |
Why?
|
| Narration | 1 | 2024 | 20 | 0.060 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2024 | 6 | 0.060 |
Why?
|
| Metabolism | 1 | 2004 | 9 | 0.060 |
Why?
|
| Infusion Pumps | 1 | 2004 | 3 | 0.060 |
Why?
|
| Mentors | 1 | 2024 | 39 | 0.060 |
Why?
|
| Syringes | 1 | 2004 | 8 | 0.060 |
Why?
|
| Viral Load | 1 | 2024 | 31 | 0.060 |
Why?
|
| Tryptophan | 1 | 2024 | 39 | 0.060 |
Why?
|
| Publishing | 1 | 2024 | 34 | 0.060 |
Why?
|
| Ethics, Research | 1 | 2024 | 38 | 0.060 |
Why?
|
| Feces | 1 | 2024 | 109 | 0.050 |
Why?
|
| Physical Fitness | 2 | 2000 | 62 | 0.050 |
Why?
|
| Homes for the Aged | 2 | 1994 | 7 | 0.050 |
Why?
|
| Physical Endurance | 1 | 2003 | 91 | 0.050 |
Why?
|
| C-Peptide | 1 | 2022 | 8 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2003 | 206 | 0.050 |
Why?
|
| Oxytocin | 1 | 2021 | 6 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 2021 | 89 | 0.050 |
Why?
|
| Hair | 1 | 2001 | 15 | 0.050 |
Why?
|
| Eating | 1 | 2021 | 70 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 179 | 0.040 |
Why?
|
| Densitometry | 1 | 2000 | 9 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 1591 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 11 | 0.040 |
Why?
|
| Weight Lifting | 1 | 2000 | 49 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 137 | 0.040 |
Why?
|
| Optical Imaging | 1 | 2020 | 34 | 0.040 |
Why?
|
| Ireland | 1 | 2019 | 16 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 193 | 0.040 |
Why?
|
| Breast Milk Expression | 1 | 2018 | 2 | 0.040 |
Why?
|
| Lactose | 1 | 2018 | 6 | 0.040 |
Why?
|
| Prognosis | 1 | 2021 | 802 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2018 | 134 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2018 | 189 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2018 | 78 | 0.040 |
Why?
|
| Ergometry | 1 | 1997 | 7 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2015 | 2546 | 0.030 |
Why?
|
| Acceleration | 1 | 1997 | 17 | 0.030 |
Why?
|
| Neuromuscular Junction | 1 | 1997 | 22 | 0.030 |
Why?
|
| Arm | 1 | 1997 | 37 | 0.030 |
Why?
|
| Motor Skills | 1 | 1997 | 34 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 1997 | 72 | 0.030 |
Why?
|
| Exercise Test | 3 | 2003 | 248 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2016 | 12 | 0.030 |
Why?
|
| Leg | 1 | 1997 | 134 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2016 | 26 | 0.030 |
Why?
|
| Fetal Weight | 1 | 2015 | 8 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 18 | 0.030 |
Why?
|
| Glycated Hemoglobin A | 1 | 2015 | 64 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2015 | 54 | 0.030 |
Why?
|
| Family | 1 | 2015 | 98 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2015 | 417 | 0.030 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1994 | 2 | 0.030 |
Why?
|
| Animals | 2 | 2021 | 10415 | 0.030 |
Why?
|
| Parkinson Disease, Secondary | 1 | 1994 | 2 | 0.030 |
Why?
|
| Cattle | 1 | 2015 | 388 | 0.030 |
Why?
|
| Adolescent Development | 1 | 2013 | 8 | 0.030 |
Why?
|
| Prevalence | 1 | 2015 | 497 | 0.030 |
Why?
|
| Logistic Models | 1 | 1994 | 407 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 385 | 0.030 |
Why?
|
| Geriatric Psychiatry | 1 | 1992 | 1 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 1994 | 243 | 0.020 |
Why?
|
| Education, Nursing, Continuing | 1 | 1992 | 7 | 0.020 |
Why?
|
| Education, Continuing | 1 | 1992 | 11 | 0.020 |
Why?
|
| Mental Processes | 1 | 1992 | 16 | 0.020 |
Why?
|
| Benzodiazepines | 1 | 1992 | 10 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 78 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 1992 | 29 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 1992 | 29 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 1992 | 34 | 0.020 |
Why?
|
| Blood Donors | 1 | 1992 | 4 | 0.020 |
Why?
|
| Diastole | 1 | 1992 | 22 | 0.020 |
Why?
|
| Systole | 1 | 1992 | 24 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 16 | 0.020 |
Why?
|
| Extracellular Fluid | 1 | 2011 | 3 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2011 | 12 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 155 | 0.020 |
Why?
|
| Hand Strength | 1 | 2011 | 38 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 258 | 0.020 |
Why?
|
| Mice | 1 | 2021 | 4650 | 0.020 |
Why?
|
| Compliance | 1 | 2011 | 21 | 0.020 |
Why?
|
| Puberty | 1 | 2011 | 13 | 0.020 |
Why?
|
| Sodium Compounds | 1 | 2010 | 2 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2012 | 271 | 0.020 |
Why?
|
| Body Size | 1 | 2009 | 37 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 1994 | 2021 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 722 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2007 | 10 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 1992 | 2377 | 0.020 |
Why?
|
| Glycerol | 1 | 2004 | 16 | 0.010 |
Why?
|
| Epinephrine | 1 | 2003 | 37 | 0.010 |
Why?
|
| Neoplasms | 1 | 2012 | 808 | 0.010 |
Why?
|
| Scalp | 1 | 2001 | 14 | 0.010 |
Why?
|
| Face | 1 | 2001 | 26 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2000 | 79 | 0.010 |
Why?
|